Baird Venture Partners this week said that Gregg Fergus has joined the company as executive-in-residence. Fergus will also become senior vice president of corporate development for Caden Biosciences, a BVP portfolio company that specializes in G-protein coupled receptor biology.
Prior to joining BVP, Fergus was with Affymetrix for nine years, and most recently served as senior vice president of sales and global operations. Fergus has also been employed by Covance and Amersham, now part of GE Healthcare. He holds a BS in bacteriology from the University of Wisconsin.
Metabolon has appointed three new members to its executive team, the company said this week:
Tim Germann was named vice president of sales. He previously headed the sales and marketing branch of US Genomics and was involved in product launches at Affymetrix.
Bruce Mcreedy was named new vice president of strategic development. He was an associate vice president of infectious diseases with LabCorp and was associate vice president at Triangle Pharmaceuticals and CEO at Fulcrum.
Dan Stevens has been named director of marketing. Stevens was formerly at Silicon Graphics and launched products at Procter and Gamble.